A. Hammerman, S. Greenberg-Dotan, E. Battat, I. Feldhamer, H. Bitterman, and B. Brenner, “The ‘real-life’ impact of adding bevacizumab to first-line therapy in metastatic colorectal cancer patients: A large Israeli retrospective cohort study”, AO, vol. 54, no. 2, pp. 164–170, Feb. 2015.